| Preview
Full Doc
 | 2003 |
Agreement and Plan of Merger
Agreement and Plan of Merger (175K)
Doc #170628: Click preview link for longer preview.
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
NOVITRON INTERNATIONAL, INC.;
CLINICAL DATA INC.;
AND
GROUP PRACTICE SERVICES INCORPORATED
Dated as of April 29, 2003
TABLE OF CONTENTS
Page
ARTICLE I DEFINITIONS 2
Section 1.1. Accounts Payable. 2
Section 1.2. Accounts Receivable. 2
Section 1.3. Affiliate. 2
Section 1.4. Agreement. 2
Section 1.5. Business. 2
Section 1.6. Certificate of Merger. 2
Section 1.7. Code. 2
Section 1.8. Confidentiality Agreement. 3
Section 1.9. Contracts. 3
Section 1.10. DGCL. 3
Section 1.11. Dissenting Shares. 3
Section 1.12. DOL. 3
Section 1.13. Effective Time. 3
Section 1.14. Elan Purchase Agreement. 3
Section 1.15. Environmental Claim. 3
Section 1.16. Environmental Laws. 3
Section 1.17. ERISA. 3
Section 1.18. Exchange Act. 3
Section 1.19. GAAP. 4
Section 1.20. Governmental Authority. 4
Section 1.21. GPSI. 4
Section 1.22. GPSI Beneficiary. 4
Section 1.23. GPSI Benefit Plans. 4
Section 1.24. GPSI Certificates. 4
Section 1.25. GPSI Common Stock. 4
Section 1.26. GPSI Contracts. 4
Section 1.27. GPSI Disclosure Schedule. 4
Section 1.28. GPSI Dissenting Holder. 4
Section 1.29. GPSI ERISA Affiliate. 4
Section 1.30. GPSI Financial Statements. 5
Section 1.31. GPSI Preferred Stock. 5
Section 1.32. GPSI Share or GPSI Shares. 5
Section 1.33. GPSI Signing Stockholders. 5
Section 1.34. GPSI Stockholder Approval. 5
Section 1.35. GPSI Stockholders. 5
Section 1.36. GPSI Subsidiaries. 5
Section 1.37. Intellectual Property. 5
Section 1.38. IRS. 6
Section 1.39. Kirk. 6
Section 1.40. Knowledge of GPSI. 6
Section 1.41. Knowledge of Parent. 6
Section 1.42. Landmark. 6
Section 1.43. Landmark Merger Agreement. 6
Section 1.44. Law. 6
Section 1.45. Lien. 6
Section 1.46. Material Adverse Effect. 7
Section 1.47. Merger. 7
Section 1.48. Merger Closing. 7
Section 1.49. Merger Closing Date. 7
Section 1.50. Merger Consideration. 7
Section 1.51. Merger Subsidiary. 7
Section 1.52. Merger Subsidiary Common Stock. 7
Section 1.53. NASDAQ. 7
Section 1.54. Parent. 7
Section 1.55. Parent Beneficiary 7
Section 1.56. Parent Benefit Plans. 8
Section 1.57. Parent Common Stock. 8
Section 1.58. Parent ERISA Affiliate. 8
Section 1.59. Parent Financial Statements. 8
Section 1.60. Parent Preferred Stock. 8
Section 1.61. Parent Proxy Statement. 8
Section 1.62. Parent SEC Documents. 8
Section 1.63. Parent Series A Preferred Stock. 8
Section 1.64. Parent Special Meeting. 8
Section 1.65. Parent Stockholder Approval. 9
Section 1.66. Permits. 9
Section 1.67. Permitted Liens. 9
Section 1.68. Person. 9
Section 1.69. PPM. 9
Section 1.70. Prime Rate. 9
Section 1.71. Registrable Security or Securities. 9
Section 1.72. Restricted Security. 10
Section 1.73. Restructuring. 10
Section 1.74. SEC. 10
Section 1.75. Securities Act. 10
Section 1.76. Shelf Registration Statement. 10
Section 1.77. Subsidiary. 10
Section 1.78. Surviving Corporation. 10
Section 1.79. Tax; Taxes. 10
Section 1.80. Tax Return. 11
ARTICLE II THE MERGER 11
Section 2.1. The Merger. 11
Section 2.2. Certificate of Incorporation and Bylaws. 11
Section 2.3. Board of Directors. 12
Section 2.4. Management. 12
Section 2.5. Effect on Capital Stock. 12
Section 2.6. Exchange of GPSI Certificates. 13
Section 2.7. Anti-Dilution Provisions. 14
ARTICLE III STOCKHOLDER APPROVAL; EFFECTIVE TIME; CLOSING 15
Section 3.1. Stockholder Approval. 15
Section 3.2. Effective Time. 15
Section 3.3. Time and Place of Merger Closing. 15
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF GPSI 15
Section 4.1. Organization and Authority of GPSI and the GPSI Subsidiaries. 16
Section 4.2. Capitalization. 16
Section 4.3. Authority Relative to this Agreement; Recommendation. 18
Section 4.4. Consents and Approvals; No Violations. 19
Section 4.5. Title to and Condition of Assets. 19
Section 4.6. Absence of Certain Events. 19
Section 4.7. Subsidiaries. 20
Section 4.8. Consolidated Financial Statements. 20
Section 4.9. Litigation. 21
Section 4.10. Employee Benefit Plans Matters. 21
Section 4.11. Labor Matters. 23
Section 4.12. Tax Matters. 24
Section 4.13. Compliance with Law. 25
Section 4.14. Fees and Expenses of Brokers and Others. 25
Section 4.15. Absence of Undisclosed Liabilities. 25
Section 4.16. Environmental Laws and Regulations. 25
Section 4.17. Intellectual Property. 26
Section 4.18. Insurance. 27
Section 4.19. Books and Records. 27
Section 4.20. Accounts Receivable and Accounts Payable. 27
Section 4.21. Material Contracts. 28
Section 4.22. Real or Personal Property. 29
Section 4.23. Vote Required. 29
Section 4.24. Full Disclosure. 29
Section 4.25. Cash; Cancellation of Master Promissory Note. 50
ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUBSIDIARY 29
Section 5.1. Organization and Authority of the Parent. 29
Section 5.2. Capitalization. 30
Section 5.3. Authority Relative to this Agreement. 30
Section 5.4. Consents and Approvals; No Violations. 31
Section 5.5. SEC Documents. 31
Section 5.6. Fees and Expenses of Brokers and Others. 32
Section 5.7. Absence of Certain Events. 32
Section 5.8. Compliance with Law. 33
Section 5.9. Absence of Undisclosed Liabilities. 33
Section 5.10. Environmental Laws and Regulations. 33
Section 5.11. Vote Required; Board Approval. 34
Section 5.12. Parent Proxy Statement; PPM; Shelf Registration Statement. 34
Section 5.13. Litigation. 35
Section 5.14. Employee Benefit Plans Matters. 35
Section 5.15. Tax Matters. 37
Section 5.16. Listing. 38
Section 5.17. Full Disclosure. 38
ARTICLE VI COVENANTS RELATING TO CONDUCT OF BUSINESS 38
Section 6.1. Conduct of Business of GPSI. 38
Section 6.2. Conduct of Business of Parent. 40
ARTICLE VII ADDITIONAL AGREEMENTS 41
Section 7.1. Parent Stockholder Meeting. 41
Section 7.2. The Parent Proxy Statement. 41
Section 7.3. PPM. 42
Section 7.4. Shelf Registration Statement. 43
Section 7.5. Obligations of Parent. 43
Section 7.6. NASDAQ Listing. 46
Section 7.7. Restructuring. 47
Section 7.8. Access to Information. 47
Section 7.9. Reasonable Efforts; Notification. 47
Section 7.10. Fees and Expenses. 48
Section 7.11. Public Announcements. 48
Section 7.12. Indemnification of Directors, Officers and Other Individuals. 49
Section 7.13. Agreement to Defend. 49
Section 7.14. Amendment of Schedules. 49
Section 7.15. Reorganization Status. 49
Section 7.16. Other Actions. 50
Section 7.17. Legends. 50
ARTICLE VIII CONDITIONS PRECEDENT TO CONSUMMATION OF THE MERGER 50
Section 8.1. Conditions Precedent to Obligations of Parent and Merger Subsidiary. 50
Section 8.2. Conditions Precedent to Obligations of GPSI. 52
ARTICLE IX TERMINATION; AMENDMENT; WAIVER 53
Section 9.1. Termination. 53
Section 9.2. Effect of Termination. 54
Section 9.3. Amendment. 54
Section 9.4. Extension; Waiver. 54
Section 9.5. Procedure for Termination, Amendment, Extension or Waiver. 54
ARTICLE X MISCELLANEOUS 55
Section 10.1. Entire Agreement; Assignment. 55
Section 10.2. Interpretation. 55
Section 10.3. Notices. 55
Section 10.4. Governing Law. 56
Section 10.5. Parties in Interest. 56
Section 10.6. Counterparts. 57
Section 10.7. Severability. 57
EXHIBITS AND SCHEDULES
EXHIBITS
Exhibit 1.40 Knowledge of GPSI
Exhibit 1.41 Knowledge of Parent
Exhibit 1.63 Certificate of Designation
Exhibit 2.1 Certificate of Merger
Exhibit 4.8 GPSI Financial Statements
Exhibit 7.7 Restructuring
DISCLOSURE SCHEDULES
GPSI Disclosure Schedule
Parent Disclosure Schedule
AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of April 29, 2003, by and among NOVITRON INTERNATIONAL, INC., a Delaware corporation ("Parent"), CLINICAL DATA INC., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Subsidiary"), and GROUP PRACTICE SERVICES INCORPORATED, a Delaware corporation ("GPSI"), recites and provides as follows:
RECITALS
WHEREAS, the respective Boards of Directors of Parent, Merger Subsidiary and GPSI have approved the merger of GPSI with and into Merger Subsidiary, with the Merger Subsidiary being the surviving corporation (the "Merger"), upon the terms and subject to the conditions of this Agreement and whereby each issued and outstanding share of GPSI Common Stock and each issued and outstanding share of GPSI Preferred Stock will be converted into shares of Parent Series A Preferred Stock, as provided herein;
WHEREAS, the Board of Directors of Parent has agreed that upon Parent Stockholder Approval, the shares of Parent Series A Preferred Stock held by the GPSI Stockholders will be convertible into shares of Parent Common Stock;
WHEREAS, the Board of Directors of Parent has recommended that its stockholders approve and adopt the transactions contemplated by this Agreement and will submit for consideration, adoption and approval to the stockholders of Parent at the Parent Special Meeting, the transactions contemplated by this Agreement;
WHEREAS, the GPSI Signing Stockholders intend to execute in accordance with the applicable provisions of the DGCL and the Certificate of Incorporation and Bylaws of GPSI, a non-unanimous written consent adopting and approving this Agreement, the Merger and the transactions contemplated hereby;
WHEREAS, GPSI, Merger Subsidiary and Parent desire to make certain representations, warranties, covenants and agreements in connection with the Merger and also to prescribe various conditions to the Merger; and
WHEREAS, for Federal income Tax purposes, it is intended that the Merger shall constitute a reorganization within the meaning of Section 368 of the Code and the regulations promulgated thereunder.
AGREEMENT
NOW, THEREFORE, in consideration of the premises, which are incorporated into and made part of this Agreement, and of the mutual representations, warranties, covenants, agreements and conditions set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
DEFINITIONS
Accounts Payable.
"Accounts Payable" shall mean payables from the operations of GPSI and the GPSI Subsidiaries arising in the ordinary course of the Business as of the Merger Closing.
- Accounts Receivable.
"Accounts Receivable" shall mean all accounts receivable, security deposits, notes receivable, prepaids and associated rights owned by GPSI and the GPSI Subsidiaries and arising in the ordinary course of the Business as of the Merger Closing.
- Affiliate.
"Affiliate" shall have the meaning set forth in Rule 145 of the SEC pursuant to the Securities Act.
- Agreement.
"Agreement" shall have the meaning set forth in the preamble to this Agreement.
- Business.
"Business" shall mean all of the business of GPSI and the GPSI Subsidiaries, including, without limitation, the businesses relating to (a) the management of, and/or provision of consulting services to, physician office laboratories, (b) the ownership and operation of moderately complex reference laboratories, (c) the provision of sales and support services to Landmark, (d) the sales of laboratory reagents and supplies, and (e) the refurbishing, sales and maintenance of laboratory equipment.
- Certificate of Merger.
"Certificate of Merger" shall have the meaning set forth in Section 2.1 hereof.
- Code.
"Code" shall mean the Internal Revenue Code of 1986, as amended.
- Confidentiality Agreement.
"Confidentiality Agreement" shall have the meaning set forth in Section 7.8 hereof.
- Contracts.
"Contracts" shall mean all contracts, agreements, leases, licenses, arrangements, understandings, relationships and commitments, whether written or oral (and all amendments, side letters, modifications and supplements thereto).
- DGCL.
"DGCL" shall mean the Delaware General Corporation Law, as amended.
- Dissenting Shares.
"Dissenting Shares" shall have the meaning set forth in Section 2.5(c) hereof.
- DOL.
"DOL" shall have the meaning set forth in Section 4.10(a) hereof.
- Effective Time.
"Effective Time" shall have the meaning set forth in Section 3.2 hereof.
- Elan Purchase Agreement.
"Elan Purchase Agreement" shall mean the Asset Purchase Agreement, dated as of December 9, 2002, by and among Elan Pharmaceuticals, Inc., Elan Diagnostics, Inc. and Parent, as it may be amended from time to time.
- Environmental Claim.
"Environmental Claim" shall have the meaning set forth in Section 4.16(b) hereof.
- Environmental Laws.
"Environmental Laws" shall have the meaning set forth in Section 4.16(a) hereof.
- ERISA.
"ERISA" shall have the meaning set forth in Section 4.10(a) hereof.
- Exchange Act.
"Exchange Act" shall mean the Securities Exchange Act of 1934, as amended.
- GAAP.
"GAAP" shall mean generally accepted accounting principles as in effect in the United States of America at the time of the preparation of the subject financial statement.
- Governmental Authority.
"Governmental Authority" shall mean any federal, state, provincial, municipal or other governmental department, commission, board, bureau, agency, instrumentality or arbitration panel, or any court, in each case whether of the United States, any of its possessions or territories, or of any foreign nation.
- GPSI.
"GPSI" shall have the meaning set forth in the preamble to this Agreement.
- GPSI Beneficiary.
"GPSI Beneficiary" shall have the meaning set forth in Section 4.10(a) hereof.
170628
|
Clinical Data
As referenced in this Agreement and Plan of Merger:
CLINICAL DATA INC. –
Merger Agreement of GPSI
EX-2 4 mergeragrgpsi.htm EXHIBIT 2.2
Exhbit 2.2
EXECUTION COPY
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
NOVITRON INTERNATIONAL, INC.;
CLINICAL DATA INC. ;
AND
GROUP PRACTICE SERVICES INCORPORATED
Dated as of April 29, 2003
TABLE OF CONTENTS
Page
ARTICLE I DEFINITIONS 2
Section 1.1. Accounts Payable. 2
Section 1.2. Accounts
_____________
CLINICAL DATA INC. – Schedule
AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of April 29, 2003, by and among NOVITRON INTERNATIONAL, INC., a Delaware corporation ("Parent"), CLINICAL DATA INC. , a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Subsidiary"), and GROUP PRACTICE SERVICES INCORPORATED, a Delaware corporation ("GPSI"), recites and provides as follows:
RECITALS
WHEREAS, the
_____________
CLINICAL DATA INC. – written.
GROUP PRACTICE SERVICES INCORPORATED
By:___________________________________
Randal J. Kirk
Chairman of the Board
NOVITRON INTERNATIONAL, INC.
By:___________________________________
Israel M. Stein
Chairman of the Board and Chief
Executive Officer
CLINICAL DATA INC.
By:___________________________________
Israel M. Stein
Chairman of the Board and Chief
Executive Officer
_____________
dt 1464098
;
Elan Pharma
As referenced in this Agreement and Plan of Merger:
Elan Pharmaceuticals, Inc – the meaning set forth in Section 3.2 hereof.
Elan Purchase Agreement.
"Elan Purchase Agreement" shall mean the Asset Purchase Agreement, dated as of December 9, 2002, by and among Elan Pharmaceuticals, Inc ., Elan Diagnostics, Inc. and Parent, as it may be amended from time to time.
Environmental Claim.
"Environmental Claim" shall have the meaning set forth in Section 4.16(b)
_____________
dt 1393894
;
|
 Eckert Seamans
As referenced in this Agreement and Plan of Merger:
Eckert Seamans – delivered to GPSI a certificate to that effect.
GPSI shall have received the opinion of Eckert Seamans Cherin & Mellott, LLC, counsel to Parent and Merger Subsidiary, dated the Merger Closing
Eckert Seamans – B. Malman, Esq.
Telephone: (212) 397-1100
Telecopy: (212) 265-9078
with a copy to:
Eckert Seamans Cherin & Mellott, LLC
Boston One International Place
18th Floor
Boston, MA 02110
Attention:
dt 35864
;
Novitron International, Inc.;
Group Practice Services Incorporated
|
| Preview
Full Doc
| 2004 |
Agreement and Plan of Merger and Reorganization
Agreement and Plan of Merger and Reorganization (388K)
Doc #329586: Click preview link for longer preview.
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AMONG
VIROLOGIC, INC.
APOLLO ACQUISITION SUB, INC.
APOLLO MERGER SUBSIDIARY, LLC
AND
ACLARA BIOSCIENCES, INC.
DATED AS OF MAY 28, 2004
TABLE OF CONTENTS
. . .
329586
|
ACLARA
As referenced in this Agreement and Plan of Merger and Reorganization:
ACLARA BIOSCIENCES, INC. – a99422exv99w1.txt
{DESCRIPTION}EXHIBIT 99.1
{TEXT}
{PAGE}
EXHIBIT 99.1
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AMONG
VIROLOGIC, INC.
APOLLO ACQUISITION SUB, INC.
APOLLO MERGER SUBSIDIARY, LLC
AND
ACLARA BIOSCIENCES, INC.
DATED AS OF MAY 28, 2004
{PAGE}
TABLE OF CONTENTS
{TABLE}
{CAPTION}
PAGE
{S} {C}
ARTICLE I THE TRANSACTION........................................................................... 2
1.1 The Transaction............................................................................... 2
1.2 Effective Time;
_____________
ACLARA BioSciences, Inc. – a wholly owned subsidiary of Parent ("MERGER SUB I"), Apollo Merger Subsidiary,
LLC, a Delaware limited liability company ("MERGER SUB II" and, together with
Merger Sub I, "MERGER SUBS") and ACLARA BioSciences, Inc. , a Delaware
corporation (the "COMPANY").
RECITALS
A. Upon the terms and subject to the conditions of this Agreement, Parent,
Merger Subs and the Company intend to effect (1) a
_____________
ACLARA BioSciences,
Inc. – the Effective Time of Merger I,
Article I of the Certificate of Incorporation of Surviving Entity I shall be
amended to read as follows: "The name of the corporation is ACLARA BioSciences,
Inc. "
(b) At the Effective Time of Merger I, the Bylaws of Surviving
Entity I shall be amended and restated in their entirety to be identical to the
Bylaws of
_____________
ACLARA BioSciences, Inc. – 635-0397
with copies to:
Cooley Godward LLP
4401 Eastgate Mall
San Diego, California 92121
Attention: Steven M. Przesmicki
Fax No.: (858) 550-6420
(b) if to the Company, to:
ACLARA BioSciences, Inc.
1288 Pear Avenue
Mountain View, California 94043
Attn: Alfred G. Merriweather
Fax No.: (650) 210-1210
74.
{PAGE}
with a copy to:
Latham & Watkins
135 Commonwealth Drive
Menlo Park,
_____________
ACLARA BIOSCIENCES, INC. – hereto have caused this Agreement to be
executed by their duly authorized respective officers as of the date first
written above.
VIROLOGIC, INC.
By: /s/ William D. Young
--------------------------------
Name:
------------------------------
Title:
-----------------------------
ACLARA BIOSCIENCES, INC.
By: /s/ Thomas G. Klopack
-----------------------------
Name: Thomas G. Klopack
-----------------------------
Title: CEO
-----------------------------
APOLLO ACQUISITION SUB, INC.
By: /s/ William D. Young
-------------------------------
Name:
-----------------------------
Title:
-----------------------------
APOLLO MERGER SUBSIDIARY, LLC
By: /s/ William
_____________
dt 1453647
;
ACLARA
As referenced in this Agreement and Plan of Merger and Reorganization:
ACLARA BIOSCIENCES, INC. – a99422exv99w1.txt
{DESCRIPTION}EXHIBIT 99.1
{TEXT}
{PAGE}
EXHIBIT 99.1
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AMONG
VIROLOGIC, INC.
APOLLO ACQUISITION SUB, INC.
APOLLO MERGER SUBSIDIARY, LLC
AND
ACLARA BIOSCIENCES, INC.
DATED AS OF MAY 28, 2004
{PAGE}
TABLE OF CONTENTS
{TABLE}
{CAPTION}
PAGE
{S} {C}
ARTICLE I THE TRANSACTION........................................................................... 2
1.1 The Transaction............................................................................... 2
1.2 Effective Time;
_____________
ACLARA BioSciences, Inc. – a wholly owned subsidiary of Parent ("MERGER SUB I"), Apollo Merger Subsidiary,
LLC, a Delaware limited liability company ("MERGER SUB II" and, together with
Merger Sub I, "MERGER SUBS") and ACLARA BioSciences, Inc. , a Delaware
corporation (the "COMPANY").
RECITALS
A. Upon the terms and subject to the conditions of this Agreement, Parent,
Merger Subs and the Company intend to effect (1) a
_____________
ACLARA BioSciences,
Inc. – the Effective Time of Merger I,
Article I of the Certificate of Incorporation of Surviving Entity I shall be
amended to read as follows: "The name of the corporation is ACLARA BioSciences,
Inc. "
(b) At the Effective Time of Merger I, the Bylaws of Surviving
Entity I shall be amended and restated in their entirety to be identical to the
Bylaws of
_____________
ACLARA BioSciences, Inc. – 635-0397
with copies to:
Cooley Godward LLP
4401 Eastgate Mall
San Diego, California 92121
Attention: Steven M. Przesmicki
Fax No.: (858) 550-6420
(b) if to the Company, to:
ACLARA BioSciences, Inc.
1288 Pear Avenue
Mountain View, California 94043
Attn: Alfred G. Merriweather
Fax No.: (650) 210-1210
74.
{PAGE}
with a copy to:
Latham & Watkins
135 Commonwealth Drive
Menlo Park,
_____________
ACLARA BIOSCIENCES, INC. – hereto have caused this Agreement to be
executed by their duly authorized respective officers as of the date first
written above.
VIROLOGIC, INC.
By: /s/ William D. Young
--------------------------------
Name:
------------------------------
Title:
-----------------------------
ACLARA BIOSCIENCES, INC.
By: /s/ Thomas G. Klopack
-----------------------------
Name: Thomas G. Klopack
-----------------------------
Title: CEO
-----------------------------
APOLLO ACQUISITION SUB, INC.
By: /s/ William D. Young
-------------------------------
Name:
-----------------------------
Title:
-----------------------------
APOLLO MERGER SUBSIDIARY, LLC
By: /s/ William
_____________
dt 1305132
;
Citibank
As referenced in this Agreement and Plan of Merger and Reorganization:
Citibank, N.A. – connection with such suit, together
with interest on the amounts set forth in this Section 7.3(b) at the prime rate
of Citibank, N.A. in effect on the date such payment was required to be made.
(v) Certain Definitions. For the purposes of this Section
7.
_____________
dt 638685
;
|
ViroLogic
As referenced in this Agreement and Plan of Merger and Reorganization:
VIROLOGIC, – {DOCUMENT}
{TYPE}EX-99.1
{SEQUENCE}2
{FILENAME}a99422exv99w1.txt
{DESCRIPTION}EXHIBIT 99.1
{TEXT}
{PAGE}
EXHIBIT 99.1
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AMONG
VIROLOGIC, INC.
APOLLO ACQUISITION SUB, INC.
APOLLO MERGER SUBSIDIARY, LLC
AND
ACLARA BIOSCIENCES, INC.
DATED AS OF MAY 28, 2004
{PAGE}
TABLE OF CONTENTS
{TABLE}
{CAPTION}
PAGE
{S} {C}
ARTICLE
_____________
ViroLogic, – v-
{PAGE}
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
This AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (the "AGREEMENT") is
made and entered into as of May 28, 2004 among ViroLogic, Inc., a Delaware
corporation ("PARENT"), Apollo Acquisition Sub, Inc., a Delaware corporation and
a wholly owned subsidiary of Parent ("MERGER SUB I"), Apollo Merger Subsidiary,
LLC, a Delaware limited
_____________
ViroLogic, – set forth below, or pursuant to such other instructions as
may be designated in writing by the party to receive such notice:
(a) if to Parent or Merger Subs, to:
ViroLogic, Inc.
345 Oyster Point Blvd.
South San Francisco, California 94080
Attention: Kathy H. Hibbs
Fax No.: (650) 635-0397
with copies to:
Cooley Godward LLP
4401 Eastgate Mall
San
_____________
VIROLOGIC, – ENFORCEMENT HEREOF.
77.
{PAGE}
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
executed by their duly authorized respective officers as of the date first
written above.
VIROLOGIC, INC.
By: /s/ William D. Young
--------------------------------
Name:
------------------------------
Title:
-----------------------------
ACLARA BIOSCIENCES, INC.
By: /s/ Thomas G. Klopack
-----------------------------
Name: Thomas G. Klopack
-----------------------------
Title: CEO
-----------------------------
APOLLO ACQUISITION SUB, INC.
By: /s/ William
_____________
ViroLogic, – Title:
-----------------------------
***MERGER AGREEMENT***
78.
{PAGE}
EXHIBIT A
CONTINGENT VALUE RIGHTS AGREEMENT
[Filed, by incorporation by reference, as Exhibit
99.2 to the Current Report on Form 8-K filed by
ViroLogic, Inc. on June 1, 2004.]
{PAGE}
EXHIBIT B
PARENT VOTING AGREEMENT
[Filed as Exhibit 99.4 to the Current Report on Form 8-K
filed by ViroLogic, Inc. on
_____________
dt 1353126
;
 Citibank
As referenced in this Agreement and Plan of Merger and Reorganization:
Citibank, N.A. – connection with such suit, together
with interest on the amounts set forth in this Section 7.3(b) at the prime rate
of Citibank, N.A. in effect on the date such payment was required to be made.
(v) Certain Definitions. For the purposes of this Section
7.
_____________
dt 638685
;
More... |
| Preview
Full Doc
| 2004 |
Agreement and Plan of Merger
Agreement and Plan of Merger (325K)
Doc #381984: Click preview link for longer preview.
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
FISHER SCIENTIFIC INTERNATIONAL INC.,
FOX MERGER CORPORATION
AND
APOGENT TECHNOLOGIES INC.
DATED AS OF MARCH 17, 2004
{PAGE}
AGREEMENT AND PLAN OF MERGER
TABLE OF CONTENTS
{TABLE}
{S} {C}
ARTICLE I THE MERGER..................................................................... 2
SECTION 1.1 The Merger............................................................... 2
SECTION 1.2 Closing.................................................................. 2
SECTION 1.3 Effective Time........................................................... 2
SECTION 1.4 Effects of the Merger.................................................... 2
SECTION 1.5 Organizational Documents of the Surviving Corporation.................... 2
SECTION 1.6 Directors and Officers of the Surviving Corporation...................... 3
SECTION 1.7 Alternative Structure.................................................... 3
ARTICLE II EFFECTS OF THE MERGER; EXCHANGE OF CERTIFICATES............................... 3
SECTION 2.1 Effect on Capital Stock................................................. 3
SECTION 2.2 Exchange of Shares and Certificates...................................... 5
ARTICLE III REPRESENTATIONS AND WARRANTIES.............................................. 8
SECTION 3.1 Representations and Warranties of Apogent................................ 8
(a) Organization, Standing and Corporate Power;
Charter Documents; Subsidiaries......... 8
(b) Capital Structure.................................................. 9
(c) Authority; Board Approval; Voting Requirements; No Conflict;
Required Filings and Consents 11
(d) SEC Documents; Financial Statements............................... 14
(e) Information Supplied.............................................. 15
(f) Absence of Certain Changes or Events.............................. 16
(g) Compliance with Applicable Laws; Permits; Litigation.............. 16
(h) Labor and Other Employment Matters................................ 18
(i) Benefit Plans..................................................... 19
(j) Taxes............................................................. 22
(k) Interested Party Transactions..................................... 25
(l) Environmental Matters............................................. 25
(m) Intellectual Property............................................. 25
(n) State Takeover Statutes........................................... 26
(o) Brokers .......................................................... 27
(p) Opinion of Financial Advisor...................................... 27
(q) Material Contracts................................................ 27
(r) Real Property..................................................... 30
(s) Apogent Rights Agreement.......................................... 30
SECTION 3.2 Representations and Warranties of Fisher and Merger Sub................. 30
(a) Organization, Standing and Corporate Power; Charter
Documents; Subsidiaries........ 31
(b) Capital Structure................................................. 32
{/TABLE}
i
{PAGE}
{TABLE}
{S} {C}
(c) Authority; Board Approval; Voting Requirements; No Conflict;
Required Filings and Consents 34
(d) SEC Documents; Financial Statements............................... 36
(e) Information Supplied.............................................. 38
(f) Absence of Certain Changes or Events.............................. 39
(g) Compliance with Applicable Laws; Permits; Litigation.............. 39
(h) Labor and Other Employment Matters................................ 41
(i) Benefit Plans..................................................... 42
(j) Taxes............................................................. 44
(k) Interested Party Transactions..................................... 46
(l) Environmental Matters............................................. 46
(m) Intellectual Property............................................. 47
(n) State Takeover Statutes........................................... 48
(o) Brokers .......................................................... 48
(p) Opinion of Financial Advisor...................................... 48
(q) Material Contracts................................................ 48
(r) Real Property..................................................... 51
(s) Merger Sub Approval............................................... 52
ARTICLE IV COVENANTS RELATING TO CONDUCT OF BUSINESS.................................... 52
SECTION 4.1 Conduct of Business..................................................... 52
SECTION 4.2 No Solicitation......................................................... 59
ARTICLE V ADDITIONAL AGREEMENTS......................................................... 62
SECTION 5.1 Preparation of SEC Documents; Shareholders' Meetings.................... 62
SECTION 5.2 Accountant's Letters.................................................... 64
SECTION 5.3 Access to Information; Confidentiality.................................. 64
SECTION 5.4 Reasonable Efforts...................................................... 65
SECTION 5.5 Indemnification and Insurance........................................... 67
SECTION 5.6 Fees and Expenses....................................................... 68
SECTION 5.7 Public Announcements.................................................... 68
SECTION 5.8 Listing................................................................. 68
SECTION 5.9 Tax-Free Reorganization Treatment....................................... 68
SECTION 5.10 Conveyance Taxes........................................................ 68
SECTION 5.11 Equity Awards and Employee Benefits..................................... 69
SECTION 5.12 Fisher Corporate Governance............................................. 70
SECTION 5.13 Affiliate Legends....................................................... 71
SECTION 5.14 Notification of Certain Matters......................................... 71
SECTION 5.15 Section 16 Matters...................................................... 71
SECTION 5.16 Rights Plans; State Takeover Laws....................................... 72
SECTION 5.17 Reservation of Fisher Common Stock...................................... 72
ARTICLE VI CONDITIONS PRECEDENT......................................................... 72
SECTION 6.1 Conditions to Each Party's Obligation to Effect the Merger.............. 72
381984
|
Apogent
As referenced in this Agreement and Plan of Merger:
APOGENT TECHNOLOGIES INC – txt
{DESCRIPTION}EX-2.1 AGREEMENT AND PLAN OF MERGER
{TEXT}
{PAGE}
EXECUTION COPY
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
FISHER SCIENTIFIC INTERNATIONAL INC.,
FOX MERGER CORPORATION
AND
APOGENT TECHNOLOGIES INC .
DATED AS OF MARCH 17, 2004
{PAGE}
AGREEMENT AND PLAN OF MERGER
TABLE OF CONTENTS
{TABLE}
{S} {C}
ARTICLE I THE MERGER..................................................................... 2
SECTION 1.1 The Merger............................................................... 2
_____________
APOGENT
TECHNOLOGIES INC – 17, 2004, by and among FISHER SCIENTIFIC INTERNATIONAL INC., a
Delaware corporation ("Fisher"), FOX MERGER CORPORATION, a Wisconsin corporation
and a direct wholly-owned subsidiary of Fisher ("Merger Sub"), and APOGENT
TECHNOLOGIES INC ., a Wisconsin corporation ("Apogent").
W I T N E S S E T H:
WHEREAS, the respective Boards of Directors of Fisher, Merger Sub and
Apogent have deemed it
_____________
Apogent Technologies Inc – Time,
Article I of the articles of incorporation of the Surviving Corporation shall be
amended and restated in its entirety to read as follows: "The name of the
corporation is Apogent Technologies Inc ." At the Effective Time,
2
{PAGE}
the Apogent Bylaws (as defined in Section 3.1(a)(ii)) shall be amended and
restated in their entirety to be identical to
_____________
Apogent Technologies Inc – proof of delivery) to the
parties at the following addresses (or at such other address for a party as
shall be specified by like notice):
(a) if to Apogent to:
Apogent Technologies Inc .
30 Penhallow Street
Portsmouth, NH 03801
Fax No.: (603) 431-0860
Attention: Michael Bresson, General Counsel
80
{PAGE}
with a copy to:
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
_____________
APOGENT TECHNOLOGIES INC – WHEREOF, Apogent, Fisher and Merger Sub have caused this
Agreement to be executed under seal by their respective officers thereunto duly
authorized, all as of the date first written above.
APOGENT TECHNOLOGIES INC .
By: /s/ Frank H. Jellinek, Jr.
_________________________________
Name: Frank H. Jellinek, Jr.
Title: Chief Executive Officer
FISHER SCIENTIFIC INTERNATIONAL INC.
By: /s/ Todd M. DuChene
_________________________________
Name: Todd M.
_____________
dt 1412771
;
Fisher
As referenced in this Agreement and Plan of Merger:
FISHER SCIENTIFIC INTERNATIONAL INC. – TYPE}EX-2.1
{SEQUENCE}3
{FILENAME}b49903atexv2w1.txt
{DESCRIPTION}EX-2.1 AGREEMENT AND PLAN OF MERGER
{TEXT}
{PAGE}
EXECUTION COPY
AGREEMENT AND PLAN OF MERGER
BY AND AMONG
FISHER SCIENTIFIC INTERNATIONAL INC. ,
FOX MERGER CORPORATION
AND
APOGENT TECHNOLOGIES INC.
DATED AS OF MARCH 17, 2004
{PAGE}
AGREEMENT AND PLAN OF MERGER
TABLE OF CONTENTS
{TABLE}
{S} {C}
ARTICLE I THE MERGER.....................................................................
_____________
FISHER SCIENTIFIC INTERNATIONAL INC. – 89
{/TABLE}
iii
{PAGE}
AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER (this "Agreement") is made and entered
into as of March 17, 2004, by and among FISHER SCIENTIFIC INTERNATIONAL INC. , a
Delaware corporation ("Fisher"), FOX MERGER CORPORATION, a Wisconsin corporation
and a direct wholly-owned subsidiary of Fisher ("Merger Sub"), and APOGENT
TECHNOLOGIES INC., a Wisconsin corporation ("Apogent").
W
_____________
Fisher Scientific International Inc. – copy to:
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, NY 10017
Fax No.: (212) 455-2502
Attention: Gary Horowitz, Esq.
(b) if to Fisher or Merger Sub, to:
Fisher Scientific International Inc.
One Liberty Lane
Hampton, NH 03842
Fax No.: (603) 929-2379
Attention: Todd M. DuChene, General Counsel
with a copy to:
Skadden, Arps, Slate, Meagher & Flom LLP
Four Times
_____________
FISHER SCIENTIFIC INTERNATIONAL INC. – thereunto duly
authorized, all as of the date first written above.
APOGENT TECHNOLOGIES INC.
By: /s/ Frank H. Jellinek, Jr.
_________________________________
Name: Frank H. Jellinek, Jr.
Title: Chief Executive Officer
FISHER SCIENTIFIC INTERNATIONAL INC.
By: /s/ Todd M. DuChene
_________________________________
Name: Todd M. DuChene
Title: Vice President, General
Counsel and Secretary
FOX MERGER CORPORATION
By: /s/ Todd M. DuChene
_________________________________
Name: Todd M.
_____________
dt 1468840
;
|
Fleet National
As referenced in this Agreement and Plan of Merger:
Fleet National Bank – share, and were reserved for issuance upon
the exercise of preferred share purchase rights (the "Apogent Rights") issued
pursuant to the Rights Agreement, dated December 11, 2000, between Apogent and
Fleet National Bank as rights agent (the "Apogent Rights Agreement"). Each
outstanding share of capital stock of Apogent is duly authorized, validly
issued, fully paid, nonassessable (subject to Section 180.0622(2)(b)
_____________
dt 1436435
;
Goldman, Sachs
As referenced in this Agreement and Plan of Merger:
Goldman, Sachs & Co. – to any
impediment or condition in connection with the exercise of any of its rights
under this Agreement or the Articles of Merger.
(o) Brokers. Except for fees payable to Goldman, Sachs & Co.
("Goldman Sachs") and Lazard Freres & Co. LLC ("Lazard"), no broker, investment
banker, financial advisor or other Person, is entitled to any broker's,
finder's, financial advisor's or
_____________
dt 1488903
;
More... |
| Preview
Full Doc
| 2004 | |
Allied Motion
As referenced in this Agreement and Plan of Merger:
ALLIED MOTION TECHNOLOGIES, INC –
Use these links to rapidly review the document
TABLE OF CONTENTS
Exhibit 99.1
AGREEMENT AND PLAN OF MERGER
by and among
ALLIED MOTION TECHNOLOGIES, INC .,
AMOT, INC.
and
OWOSSO CORPORATION
Dated as of February 10, 2004
TABLE OF CONTENTS
TABLE OF DEFINITIONS
ARTICLE I THE MERGER
Section 1.1
The Merger
Section 1.2
_____________
Allied Motion Technologies, Inc – Warrant/Warrants
3.1(b)(ii)
c
AGREEMENT AND PLAN OF MERGER
THIS AGREEMENT AND PLAN OF MERGER, dated as of February 10, 2004 (the "Agreement"), is by and among Allied Motion Technologies, Inc ., a Colorado
corporation ("Parent"), AMOT, Inc., a Pennsylvania corporation and wholly owned Subsidiary of Parent ("Merger Sub"), and Owosso Corporation, a Pennsylvania corporation (the "Company")
(collectively, the "Parties").
RECITALS
_____________
Allied
Motion Technologies, Inc – Arch Streets
Philadelphia, Pennsylvania 19103-2799
Attention: Elam M. Hitchner III, Esq.
Telephone: 215-981-4000
Telecopier: 215-981-4750
48
and
(b) if
to Parent or Merger Sub, to:
Allied
Motion Technologies, Inc .
23 Inverness Way East, Suite 150
Englewood, Colorado 80112
Attention: Mr. Richard Smith
Telephone: 303-799-8520
Telecopier: 303-799-8521
with
a copy to:
Jaeckle
Fleischmann & Mugel,
_____________
ALLIED MOTION TECHNOLOGIES, INC – IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this Agreement to be executed by their respective officers thereunto duly authori |